Autism spectrum disorder (ASD) is a common neurodevelopmental disorder with reported
prevalence in the United States of 1 in 59 children (approximately 1.7%). Core deficits are …

Autism spectrum disorder (ASD) consists of a genetically heterogenous group of
neurobehavioral disorders characterized by impairment in three behavioral domains …

Mental disorders frequently begin in childhood or adolescence. Psychotropic medications
have various indications for the treatment of mental disorders in this age group and are used …

Abstract Autism Spectrum Disorder (ASD) is a severe and lifelong neurodevelopmental
disorder, with high social costs and a dramatic burden on the quality of life of patients and …

Pervasive developmental disorders are now commonly referred to as autism spectrum
disorders (ASDs). ASDs present with a range of severity and impairments, and often are a …

Autism is a comprehensive growth abnormality in which social skills, language,
communication, and behavioral skills are developed with delay and as diversionary. The …

Current evidence-based pharmacotherapy options in children with ASD are very limited, and
many have substantial adverse events. Clinicians should use pharmacotherapy as a part of …

Aripiprazole and risperidone are the only FDA approved medications for treating irritability in
autistic disorder, however there are no head-to-head data comparing these agents. This is …

The current study prospectively examined trajectories of change in symptoms of irritability,
hyperactivity, and social withdrawal, as well as predictors of such behaviors, for ages 9–18 …

Objective This meta-analysis examined the efficacy of available pharmacological and
nonpharmacological interventions for irritability among youth with autism spectrum disorder …